What are the recommended antibiotics for treating syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antibiotics for Syphilis

Benzathine penicillin G remains the definitive first-line treatment for all stages of syphilis, with stage-specific dosing protocols that directly prevent progression to irreversible cardiovascular and neurological complications.

Primary Treatment Recommendations by Stage

Early Syphilis (Primary, Secondary, Early Latent)

  • Benzathine penicillin G 2.4 million units IM as a single dose 1, 2
  • This single injection is highly effective for preventing progression and achieving serologic cure
  • For HIV-infected patients, the same single-dose regimen is recommended, though some specialists advocate for three weekly doses (benefit remains unproven) 1

Late Latent Syphilis or Syphilis of Unknown Duration

  • Benzathine penicillin G 7.2 million units total: administered as 2.4 million units IM weekly for 3 consecutive weeks 3, 4
  • This extended regimen prevents late complications including cardiovascular and gummatous disease
  • CSF examination should be performed if neurologic/ophthalmic symptoms, treatment failure, or HIV infection with late latent disease is present 4

Neurosyphilis

  • Aqueous crystalline penicillin G 18-24 million units IV daily (administered as 3-4 million units IV every 4 hours or continuous infusion) for 10-14 days 2
  • Alternative: Procaine penicillin 2.4 million units IM daily PLUS probenecid 500 mg orally four times daily for 10-14 days 2
  • Consider adding benzathine penicillin 2.4 million units IM weekly for up to 3 weeks after completion to provide comparable total therapy duration 2

Tertiary Syphilis (Cardiovascular/Gummatous)

  • Benzathine penicillin G 7.2 million units total: 2.4 million units IM weekly for 3 weeks 3
  • CSF examination mandatory before initiating therapy to exclude neurosyphilis 3, 2
  • Manage in consultation with infectious disease specialist 2

Penicillin Allergy Alternatives

For Early Syphilis (Non-Pregnant)

  • Doxycycline 100 mg orally twice daily for 14 days 3, 5
  • Alternative: Tetracycline 500 mg orally four times daily for 14 days 3
  • Ceftriaxone 1 g IV/IM daily for 10 days is a reasonable alternative based on randomized trial data 6
  • Doxycycline has reassuring retrospective data supporting efficacy 6

Critical caveat: Azithromycin (2 g single oral dose) should NOT be used in the United States due to widespread macrolide resistance and documented treatment failures, despite some international efficacy data 1, 6, 7

For Late Latent Syphilis (Non-Pregnant)

  • Doxycycline 100 mg orally twice daily for 28 days 3
  • Alternative: Tetracycline 500 mg orally four times daily for 28 days 3

For Pregnant Patients with Penicillin Allergy

  • Penicillin desensitization is mandatory, followed by penicillin therapy 3, 4
  • No alternative antibiotics are acceptable in pregnancy—desensitization is the only option 3

Special Populations

HIV-Infected Patients

  • Use identical penicillin regimens as HIV-negative patients 1
  • Enhanced therapy (benzathine penicillin plus amoxicillin/probenecid) does NOT improve outcomes and is not recommended 1
  • Closer serologic follow-up is warranted to detect treatment failure 1
  • Limited data suggest no benefit to multiple doses over single-dose therapy for early syphilis in terms of serologic outcomes 6

Pediatric Dosing

  • Early latent: Benzathine penicillin G 50,000 units/kg IM (max 2.4 million units) as single dose 3, 4
  • Late latent: Benzathine penicillin G 50,000 units/kg IM weekly for 3 weeks (total 150,000 units/kg, max 7.2 million units total) 3, 4

Critical Follow-Up Parameters

Early Syphilis

  • Quantitative nontreponemal tests at 3 and 6 months 5
  • Treatment failure indicators: persistent/recurrent symptoms, sustained fourfold titer increase, or failure of titers to decline fourfold by 3 months 5
  • Re-treatment with three weekly benzathine penicillin doses if failure occurs 5

Latent Syphilis

  • Serologic testing at 6,12, and 24 months 3, 4
  • Re-evaluate for neurosyphilis if: titers increase fourfold, initially high titer (≥1:32) fails to decline fourfold within 12-24 months, or new symptoms develop 3, 4

Neurosyphilis

  • Repeat CSF examination every 6 months until cell count normalizes (if initially elevated) 2
  • CSF leukocyte count is the most sensitive measure of treatment effectiveness 2
  • Consider retreatment if cell count hasn't decreased after 6 months or CSF parameters not normal after 2 years 2

Common Pitfalls to Avoid

  1. Missed doses in late syphilis treatment: If a weekly dose is missed, an interval of 10-14 days between doses may be acceptable before restarting the sequence, but this is NEVER acceptable in pregnant patients—they must restart the full course 4

  2. Assuming azithromycin is equivalent: Despite meta-analysis data showing comparable efficacy 7, widespread resistance in the US makes this unacceptable 1, 6

  3. Inadequate screening frequency: HIV-infected persons and men who have sex with men require screening every 3-6 months, not annually 1

  4. Overlooking neurosyphilis: Any patient with neurologic/ophthalmic symptoms, tertiary disease manifestations, treatment failure, or HIV with late latent disease requires CSF examination 4, 2

  5. Using alternatives in pregnancy: Only penicillin after desensitization is acceptable—no exceptions 3, 4

The evidence consistently demonstrates that penicillin remains unmatched in preventing the devastating morbidity and mortality of untreated syphilis, particularly neurosyphilis and cardiovascular complications that develop in late-stage disease 3, 1, 2, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.